» Articles » PMID: 33411531

Simple Secondary Amines Inhibit Growth of Gram-Negative Bacteria Through Highly Selective Binding to Phenylalanyl-tRNA Synthetase

Overview
Journal J Am Chem Soc
Specialty Chemistry
Date 2021 Jan 7
PMID 33411531
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Antibiotics to treat drug-resistant Gram-negative infections are urgently needed but challenging to discover. Using a cell-based screen, we identified a simple secondary amine that inhibited the growth of wild-type and but not the growth of the Gram-positive organism . Resistance mutations in and mapped exclusively to the aminoacyl-tRNA synthetase PheRS. We confirmed biochemically that the compound inhibited PheRS from these organisms and showed that it did not inhibit PheRS from or humans. To understand the basis for the compound's high selectivity for only some PheRS enzymes, we solved crystal structures of and PheRS complexed with the inhibitor. The structures showed that the compound's benzyl group mimics the benzyl of phenylalanine. The other amine substituent, a 2-(cyclohexen-1-yl)ethyl group, induces a hydrophobic pocket in which it binds. Through bioinformatic analysis and mutagenesis, we show that the ability to induce a complementary hydrophobic pocket that can accommodate the second substituent explains the high selectivity of this remarkably simple molecular scaffold for Gram-negative PheRS. Because this secondary amine scaffold is active against wild-type Gram-negative pathogens but is not cytotoxic to mammalian cells, we suggest that it may be possible to develop it for use in combination antibiotic therapy to treat Gram-negative infections.

Citing Articles

Hypothetical Proteins of Reannotation and Expression Changes Identified via RNA-Sequencing.

Si D, Sun J, Guo L, Yang F, Tian X, He S Microorganisms. 2023; 11(11).

PMID: 38004728 PMC: 10673309. DOI: 10.3390/microorganisms11112716.


Facile Modification of Medical-Grade Silicone for Antimicrobial Effectiveness and Biocompatibility: A Potential Therapeutic Strategy against Bacterial Biofilms.

Wynne K, Zolotarskaya O, Jarrell R, Wang C, Amin Y, Brunson K ACS Appl Mater Interfaces. 2023; 15(40):46626-46638.

PMID: 37782835 PMC: 10969938. DOI: 10.1021/acsami.3c08734.


Antibacterial Thin Films Deposited from Propane-Butane Mixture in Atmospheric Pressure Discharge.

Stahel P, Mazankova V, Podzemna D, Podzemna E, Pizurova V, Jurmanova J Int J Mol Sci. 2023; 24(2).

PMID: 36675219 PMC: 9864540. DOI: 10.3390/ijms24021706.


Design, computational studies, synthesis and in vitro antimicrobial evaluation of benzimidazole based thio-oxadiazole and thio-thiadiazole analogues.

Noureldin N, Richards J, Kothayer H, Baraka M, Eladl S, Wootton M BMC Chem. 2021; 15(1):58.

PMID: 34711258 PMC: 8555319. DOI: 10.1186/s13065-021-00785-8.

References
1.
Mermershtain I, Finarov I, Klipcan L, Kessler N, Rozenberg H, Safro M . Idiosyncrasy and identity in the prokaryotic Phe-system: crystal structure of E. coli phenylalanyl-tRNA synthetase complexed with phenylalanine and AMP. Protein Sci. 2010; 20(1):160-7. PMC: 3047072. DOI: 10.1002/pro.549. View

2.
Anderson Jr R, Santi D . Phenylalanyl transfer ribonucleic acid synthetase from Escherichia coli B. Potent inhibition by analogues of N-benzyl-2-phenylethylamine. J Med Chem. 1976; 19(11):1270-5. DOI: 10.1021/jm00233a002. View

3.
ODwyer K, Spivak A, Ingraham K, Min S, Holmes D, Jakielaszek C . Bacterial resistance to leucyl-tRNA synthetase inhibitor GSK2251052 develops during treatment of complicated urinary tract infections. Antimicrob Agents Chemother. 2014; 59(1):289-98. PMC: 4291364. DOI: 10.1128/AAC.03774-14. View

4.
Nikaido H . Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev. 2003; 67(4):593-656. PMC: 309051. DOI: 10.1128/MMBR.67.4.593-656.2003. View

5.
Ho J, Bakkalbasi E, Soll D, Miller C . Drugging tRNA aminoacylation. RNA Biol. 2018; 15(4-5):667-677. PMC: 6103670. DOI: 10.1080/15476286.2018.1429879. View